Erica B Lee Selected Research

Erica B Lee Research Topics

Disease

29	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2020 - 03/2018
2	Atopic Dermatitis (Atopic Eczema) 02/2022 - 03/2019
2	Inflammation (Inflammations) 01/2019 - 01/2019
1	COVID-19 01/2021
1	Dermatitis 01/2021
1	Contact Dermatitis (Eczema, Contact) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Allergic Contact Dermatitis 01/2021
1	Mycoses (Diseases, Fungus) 10/2020
1	Invasive Fungal Infections 10/2020
1	Herpes Zoster 06/2020
1	Infections 06/2020
1	Ankylosing Spondylitis 06/2020
1	Psoriatic Arthritis 06/2020
1	Asthma (Bronchial Asthma) 06/2020
1	Rheumatoid Arthritis 06/2020
1	Pemphigus (Pemphigus Vulgaris) 01/2020
1	Cerebral Toxoplasmosis 01/2020
1	Pain (Aches) 08/2019
1	Lentigo (Lentiginosis) 01/2019
1	Skin Manifestations 01/2019
1	Latent Tuberculosis 11/2018
1	Tuberculosis (Tuberculoses) 11/2018

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2020 - 10/2018
4	Interleukin-17 (Interleukin 17)IBA 10/2020 - 01/2019
4	Interleukin-23 (Interleukin 23)IBA 10/2020 - 01/2019
4	Biological ProductsIBA 08/2020 - 11/2018
3	CytokinesIBA 10/2020 - 01/2019
3	secukinumabIBA 06/2020 - 01/2019
3	ixekizumabIBA 06/2020 - 01/2019
3	Tumor Necrosis Factor InhibitorsIBA 02/2020 - 09/2018
2	Adalimumab (Humira)FDA Link 08/2020 - 11/2018
2	Etanercept (Enbrel)FDA Link 08/2020 - 11/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020 - 04/2020
2	Biosimilar PharmaceuticalsIBA 08/2020 - 04/2020
2	brodalumabIBA 06/2020 - 03/2019
2	guselkumabIBA 01/2020 - 01/2019
2	apremilastIBA 10/2018 - 10/2018
1	dupilumabIBA 02/2022
1	AllergensIBA 01/2021
1	Local Anti-Infective Agents (Antiseptics)IBA 12/2020
1	Vitamin D FDA LinkGeneric 12/2020
1	Immunologic Factors (Immunomodulators)IBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	Interleukin InhibitorsIBA 10/2020
1	Interleukin-12 (IL 12)IBA 10/2020
1	CT-P13IBA 08/2020
1	Infliximab (Remicade)FDA Link 08/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	crisaboroleIBA 03/2019
1	AntibodiesIBA 03/2019
1	Phosphodiesterase 4 InhibitorsIBA 03/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2019
1	Substance PIBA 01/2019
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2019
1	tildrakizumabIBA 01/2019
1	Calcitonin Gene-Related PeptideIBA 01/2019
1	NeuropeptidesIBA 01/2019
1	Nerve Growth Factor (NGF)IBA 01/2019
1	InterleukinsIBA 01/2019
1	SteroidsIBA 07/2018
1	Janus Kinase InhibitorsIBA 03/2018

Therapy/Procedure

13	Therapeutics 11/2020 - 03/2018
3	Biological Therapy 08/2020 - 03/2018
2	Phototherapy (Light Therapy) 11/2020 - 01/2019
1	Dermatologic Surgical Procedures 01/2021
1	Personal Protective Equipment 01/2021
1	Mohs Surgery (Mohs' Micrographic Surgery) 01/2021
1	Excimer Lasers 11/2020
1	Lasers (Laser) 11/2020
1	Contraindications 08/2019